findmyKOL
Clinical trialNCT04173819CompletedPhase 1/PHASE2Interventional

Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults

SponsorInternational AIDS Vaccine InitiativeEnrollment225HIV-1-infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Kenya
  • Partners in Health Research and Development

    Thika, Kiambu County, Kenya

  • Kenya Aids Vaccine Initiative - Institute of Clinical Research

    Nairobi, Kenya

Rwanda
  • Center for Family Health Research

    Kigali, Rwanda

South Africa
  • Wits Reproductive Health and Hiv Institute

    Johannesburg, South Africa

Uganda
  • Uganda Virus Research Institute

    Entebbe, Uganda

  • Infectious Diseases Institute Kasangati

    Kampala, Uganda

United States
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • the Rockefeller University

    New York, New York, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jan 2019
Primary completion
1 Sept 2023
Completion
1 Sept 2023
Last update posted
6 May 2025
Registered enrollment
225
Registry id
NCT04173819

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.